Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NULIBRY® safely and effectively. See full prescribing information for NULIBRY. NULIBRY (fosdenopterin) for injection, for intravenous useInitial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
NULIBRY is indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.
- generic_name
- fosdenopterin hydrobromide
- product_names
- fosdenopterin hydrobromide
- ndc
- 42358-295, 42358-295-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en